NR 565 Final Exam Advanced Pharmacology Fundamentals 2026 Comprehensive Practice Questions with Answers & Rationales – Ultimate Nurse Practitioner Test Bank (Pass Guarantee)

NR 565 FINAL EXAM – ADVANCED
PHARMACOLOGY FUNDAMENTALS

COMPREHENSIVE PRACTICE QUESTIONS WITH
ANSWERS & RATIONALES




Question 1: The APRN is explaining to a patient that the drug's
"half-life" determines how often the medication needs to be
taken. Which statement best describes half-life?

A) The time required for the drug to reach its maximum
concentration in the blood
B) The time required for the drug concentration to decrease by
50%
C) The time required for the drug to be completely eliminated
from the body
D) The time required for the drug to be absorbed from the
gastrointestinal tract

Correct Answer: B) The time required for the drug
concentration to decrease by 50%

Rationale: Half-life is the time required for the serum drug
concentration to decrease by 50%. It takes approximately 4-5 half-

,lives for a drug to be eliminated from the body. Half-life determines
dosing intervals and time to reach steady-state.




Question 2: A drug that is highly protein-bound would be
expected to have which characteristic?

A) Large volume of distribution
B) Small volume of distribution
C) Rapid renal elimination
D) High first-pass metabolism

Correct Answer: B) Small volume of distribution

Rationale: Highly protein-bound drugs tend to stay in the vascular
compartment, resulting in a small volume of distribution. Only the
unbound (free) fraction is pharmacologically active and can
distribute to tissues. A large volume of distribution (A) is
characteristic of lipophilic drugs.




Question 3: Which of the following would increase the volume of
distribution of a drug?

A) High protein binding
B) High lipophilicity (fat solubility)
C) High water solubility
D) High ionization at physiological pH

Correct Answer: B) High lipophilicity (fat solubility)

,Rationale: Lipophilic drugs have a high volume of distribution
because they readily cross cell membranes and accumulate in fatty
tissues. High protein binding (A) reduces Vd. Water solubility (C)
and ionization (D) reduce Vd because the drug remains in the
vascular compartment.




Question 4: A patient with hepatic impairment is prescribed a
medication with a high first-pass effect. The APRN should
anticipate:

A) Decreased drug absorption
B) Increased drug bioavailability and risk of toxicity
C) Decreased drug distribution
D) No change in drug effect

Correct Answer: B) Increased drug bioavailability and risk of
toxicity

Rationale: Drugs with high first-pass metabolism are extensively
metabolized by the liver before reaching systemic circulation. In
hepatic impairment, first-pass metabolism is reduced, leading to
increased bioavailability and risk of toxicity. Dose reduction may be
needed.




Question 5: A patient is prescribed a medication that is a CYP3A4
inhibitor. Which drug interaction should the APRN anticipate?

, A) Decreased levels of CYP3A4 substrates
B) Increased levels of CYP3A4 substrates
C) No effect on CYP3A4 substrates
D) Decreased protein binding of CYP3A4 substrates

Correct Answer: B) Increased levels of CYP3A4 substrates

Rationale: CYP3A4 inhibitors decrease the metabolism of drugs that
are substrates for this enzyme, leading to increased serum
concentrations and potential toxicity. Examples of CYP3A4
inhibitors include ketoconazole, erythromycin, and grapefruit juice.




Question 6: Which of the following medications is a CYP3A4
inducer?

A) Ketoconazole
B) Erythromycin
C) Rifampin
D) Grapefruit juice

Correct Answer: C) Rifampin

Rationale: Rifampin is a potent CYP3A4 inducer that increases the
metabolism of other drugs, leading to decreased serum levels and
reduced effectiveness. Ketoconazole, erythromycin, and grapefruit
juice are CYP3A4 inhibitors (they increase drug levels).